U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

novavax.com/press-releases/2025-05-19-U-S-FDA-Approves-BLA-for-Novavaxs-COVID-19-Vaccine

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine
- Nuvaxovid™ is the only recombinant protein-based, non-mRNA COVID-19 vaccine available in the U.S.
- Biologics License Application approval triggers $175 million Sanofi milestone payment, with additional COVID-19 vaccine milestones…

This story appeared on novavax.com, 2025-05-19 13:31:18.376000.
The Entire Business World on a Single Page. Free to Use →